In this editorial from Future Oncology the different types of endometrial cancer are appraised.
Browsing: endometrial cancer
Researchers have demonstrated the potential prognostic value of the uterine microbiome in the development of endometrial cancer.
A team from Yale University has genetically analyzed genes involved in rare ovarian and uterine carcinosarcomas, which could potentially lead to new treatments for these aggressive tumors.
New study indicates that women carrying the BRCA gene mutation may be at increased risk of developing a lethal form of uterine cancer.
What is the role of miRNAs in endometrial cancer pathogenesis and treatment?
Study reveals gaps in specialty care for cervical, ovarian and uterine cancer throughout the USA.
This review summarizes current knowledge regarding the role of environmental factors in gynecological cancer etiology and survival, focusing on those that are potentially amenable to intervention.
Combining radiation therapy and concurrent chemotherapy postsurgery: promising results observed for high-risk endometrial cancer
A study published in the International Journal of Radiation Oncology reports results demonstrating that postsurgery radiation therapy combined with concurrent paclitaxel chemotherapy can be an effective treatment for patients with high-risk endometrial cancer.
Identification of genetic mutations could lead to better treatment possibilities in Type 1 endometrioid endometrial carcinoma
Scientists from The University of Texas MD Anderson Cancer Center (TX, USA) have recently discovered genetic mutations in endometrioid endometrial carcinoma (EEC), details of which were published recently in the Journal of the National Cancer Institute.
Among female-specific cancers worldwide, endometrial cancer is the third most common after breast cancer and cervical cancer.